0001209191-21-055140.txt : 20210908
0001209191-21-055140.hdr.sgml : 20210908
20210908162243
ACCESSION NUMBER: 0001209191-21-055140
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210907
FILED AS OF DATE: 20210908
DATE AS OF CHANGE: 20210908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alland Leila
CENTRAL INDEX KEY: 0001825216
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39539
FILM NUMBER: 211242368
MAIL ADDRESS:
STREET 1: C/O PMV PHARMACEUTICALS, INC.
STREET 2: 8 CLARKE DRIVE, SUITE 3
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PMV Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001699382
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463218129
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 642-6664
MAIL ADDRESS:
STREET 1: 8 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-07
0
0001699382
PMV Pharmaceuticals, Inc.
PMVP
0001825216
Alland Leila
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3
CRANBURY
NJ
08512
0
1
0
0
Chief Medical Officer
Common Stock
2021-09-07
4
M
0
3900
3.90
A
3900
D
Common Stock
2021-09-07
4
S
0
3900
30.25
D
0
D
Employee Stock Option (right to buy)
3.90
2021-09-07
4
M
0
3900
0.00
D
2030-02-04
Common Stock
3900
353950
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter.
/s/ Winston Kung, by power of attorney
2021-09-08